(R)-[11C]PK11195

N/A

Report date: 2025/11/25 11:44:05
NME

Base Information

Drug Name(R)-[11C]PK11195
Drug Alias Name11C-(R)-PK-11195(R)-[11C]PK-11195
ClassificationRadiation-emitting products > Nuclides > Carbon > 11CDiagnostic agent (In vivo) > Radionuclide Imaging agentRadiation-emitting products > Radioactive diagnostic agent +[5] 
Mechanisms of ActionTranslocator protein modulators
TargetsTranslocator protein
Therapy Area/IndicationsCoronavirus Disease 2019 (COVID-19)Brain Injuries, TraumaticMultiple Sclerosis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesNetherlandsFinland
CombinationsNo
Global Highest StatusClinical
Highest Status in ChinaN/A
Originator CompaniesSanofi
China Registration ClassN/A

Develop Information

Active CompaniesTurku University Hospital
Inactive CompaniesVu University Medical CenterMayo Clinic
Active IndicationsMultiple Sclerosis
Inactive IndicationsCoronavirus Disease 2019 (COVID-19)Brain Injuries, Traumatic

Other Information

ATC CodeN/A
Related LinksN/A